What is Ipamorelin?
Ipamorelin is a selective growth-hormone secretagogue that mimics ghrelin to stimulate GH release. It is often researched in combination with GHRH analogs like CJC-1295 for a more pulsatile release pattern.
Also known as: Growth hormone secretagogue
How Ipamorelin is studied
Ipamorelin is a selective growth-hormone secretagogue that mimics ghrelin at its receptor to trigger growth-hormone release. It is valued in research for a relatively "clean" profile, with less effect on appetite, cortisol, and prolactin than some older secretagogues.
Commonly researched for
Typically stacked with
Research status
Important considerations
Endocrine-active. Not an approved medication for these uses.
Ipamorelin — frequently asked questions
Stimulating growth-hormone release, with interest in recovery and body composition. It is often paired with a GHRH analog like CJC-1295.
Compared with earlier secretagogues, it tends to raise growth hormone with fewer off-target effects on cortisol, prolactin, and hunger in studies.
No, it is not an approved medication for these uses. It is endocrine-active and studied in preclinical and early human pharmacology work.